Advertisement
Advertisement

EXOZ

EXOZ logo

eXoZymes Inc. Common Stock

10.15
USD
Sponsored
-0.04
-0.39%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

10.04

-0.12
-1.13%

EXOZ Earnings Reports

Positive Surprise Ratio

No Data Available for EXOZ

0%

Next Report

Date of Next Report
Mar 31, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
--
Implied change from Q3 25 (Revenue/ EPS)
--
/
--
Implied change from Q4 24 (Revenue/ EPS)
--
/
--

eXoZymes Inc. Common Stock earnings per share and revenue

On Nov 13, 2025, EXOZ reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, eXoZymes Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Mar 31, 2026.
Based on -- analysts, eXoZymes Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement